Accendra Health, Inc. (FRA:6OM)

Germany flag Germany · Delayed Price · Currency is EUR
2.740
-0.020 (-0.72%)
At close: Jun 26, 2026
Market Cap224.28M -57.2%
Revenue (ttm)2.36B -0.0%
Net Income-938.53M
EPS-12.24
Shares Out n/a
PE Ration/a
Forward PE6.53
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open2.740
Previous Close2.760
Day's Range2.740 - 2.740
52-Week Range1.510 - 8.000
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About Accendra Health

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines includi... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies
Founded 1882
Employees 6,500
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 6OM

Financial Performance

In 2025, Accendra Health's revenue was $2.76 billion, an increase of 3.06% compared to the previous year's $2.68 billion. Losses were -$1.10 billion, 203.5% more than in 2024.

Financial numbers in USD Financial Statements

News

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the expiration and final results of the previously announced offers to exchange (the “Exchange Offers”...

3 days ago - Business Wire

Accendra Health Announces Early Results of Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced the early results of the previously announced offers to exchange (the “Exchange Offers”) any and all o...

17 days ago - Business Wire

Accendra Health Announces Offers and Consent Solicitations

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today announced that it has commenced an offer to exchange (the “Exchange Offers”) any and all of the Company's outsta...

5 weeks ago - Business Wire

Accendra Health Transcript: AGM 2026

The meeting approved all four proposals, including director elections and incentive plan. The company highlighted its transition to a pure play home-based care provider, serving most of the U.S. with a streamlined workforce and strong brand presence.

6 weeks ago - Transcripts

Accendra Health price target raised to $4.50 from $3 at UBS

UBS raised the firm’s price target on Accendra Health (ACH) to $4.50 from $3 and keeps a Neutral rating on the shares.

6 weeks ago - TheFly

Accendra Health price target raised to $6 from $5 at Baird

Baird raised the firm’s price target on Accendra Health (ACH) to $6 from $5 and keeps an Outperform rating on the shares.

6 weeks ago - TheFly

Accendra Health price target raised to $5 from $3.25 at Citi

Citi raised the firm’s price target on Accendra Health (ACH) to $5 from $3.25 and keeps a Buy rating on the shares.

6 weeks ago - TheFly

Accendra Health Earnings Call Transcript: Q1 2026

First quarter 2026 results met expectations, with revenue down 6.8% year-over-year but up 1% excluding a major payer exit. Gross margins nearly doubled post-divestiture, and a comprehensive balance sheet optimization will reduce debt and extend maturities.

6 weeks ago - Transcripts

Accendra Health Earnings release: Q1 2026

Accendra Health released its Q1 2026 earnings on May 11, 2026, summarizing the period's financial results.

6 weeks ago - Filings

Accendra Health Slides: Q1 2026

Accendra Health has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 11, 2026.

6 weeks ago - Filings

Accendra Health Quarterly report: Q1 2026

Accendra Health has published its Q1 2026 quarterly earnings report on May 11, 2026.

6 weeks ago - Filings

Accendra Health reports Q1 EPS (4c) vs. 29c last year

Reports Q1 revenue $627.8M vs. $673.9M last year. “Our first quarter results were aligned with our expectations as we continue our transformation into a pure play home based care company.

6 weeks ago - TheFly

Accendra Health backs FY26 guidance for net revenue and adjusted EBITDA

06:38 EDT Accendra Health (ACH) backs FY26 guidance for net revenue and adjusted EBITDA

6 weeks ago - TheFly

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the first quarter ended March 31, 2026, and announced a more than $1.5 billion comprehensive bala...

6 weeks ago - Business Wire

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the...

2 months ago - Business Wire

Accendra Health Proxy statement: Proxy filing

Accendra Health filed a proxy statement on April 2, 2026, providing details for shareholder voting and corporate governance matters.

3 months ago - Filings

Accendra Health Proxy statement: Proxy filing

Accendra Health filed a proxy statement on April 2, 2026, providing details for shareholder voting and corporate governance matters.

3 months ago - Filings

Accendra Health price target lowered to $3.25 from $4 at Citi

Citi lowered the firm’s price target on Accendra Health (ACH) to $3.25 from $4 and keeps a Buy rating on the shares.

4 months ago - TheFly

Accendra Health price target lowered to $3 from $4 at UBS

UBS analyst Kevin Caliendo lowered the firm’s price target on Accendra Health (ACH) to $3 from $4 and keeps a Buy rating on the shares. The firm updated the company’s…

4 months ago - TheFly

Accendra Health Earnings Call Transcript: Q4 2025

Revenue grew over 3% in 2025 to nearly $2.8B, with strong performance in sleep, ostomy, and urology. 2026 guidance reflects a $300M revenue headwind from a major payer loss, but cost reductions and technology investments are expected to support margins and cash flow.

4 months ago - Transcripts

Accendra Health Annual report: Q4 2025

Accendra Health has published its Q4 2025 annual report on February 19, 2026.

4 months ago - Filings

Accendra Health Earnings release: Q4 2025

Accendra Health released its Q4 2025 earnings on February 19, 2026, summarizing the period's financial results.

4 months ago - Filings

Accendra Health Slides: Q4 2025

Accendra Health has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 19, 2026.

4 months ago - Filings

Accendra Health Annual report: Q4 2025

Accendra Health has published its Q4 2025 annual report on February 19, 2026.

4 months ago - Filings

Accendra Health reports Q4 adjusted EPS 21c, consensus 22c

Reports Q4 revenue $709M, consensus $714.73M. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and…

4 months ago - TheFly